This Insider Has Just Sold Shares In Race Oncology Limited (ASX:RAC)

By
Simply Wall St
Published
November 30, 2021
ASX:RAC
Source: Shutterstock

Some Race Oncology Limited (ASX:RAC) shareholders may be a little concerned to see that insider William Garner recently sold a substantial AU$4.4m worth of stock at a price of AU$3.45 per share. That's a big disposal, and it decreased their holding size by 14%, which is notable but not too bad.

View our latest analysis for Race Oncology

The Last 12 Months Of Insider Transactions At Race Oncology

Notably, that recent sale by insider William Garner was not the only time they sold Race Oncology shares this year. Earlier in the year, they fetched AU$4.00 per share in a -AU$6.6m sale. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (AU$3.31). So it is hard to draw any strong conclusion from it.

In the last twelve months insiders purchased 231.28k shares for AU$762k. On the other hand they divested 6.64m shares, for AU$24m. Over the last year we saw more insider selling of Race Oncology shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
ASX:RAC Insider Trading Volume November 30th 2021

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Insider Ownership

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Race Oncology insiders own about AU$165m worth of shares (which is 34% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At Race Oncology Tell Us?

The stark truth for Race Oncology is that there has been more insider selling than insider buying in the last three months. And our longer term analysis of insider transactions didn't bring confidence, either. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For example, Race Oncology has 3 warning signs (and 2 which are significant) we think you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.